Aug 2026· Journal of Chemical Information and Modeling· Vol 66 16, pp.
10199-10214
· 0 citations· 54 references
Medicine
TL;DR
This work uncovers key dynamic features of the static and recognition pathway interaction of the ornithine decarboxylase-antizyme isoforms system and reveals critical determinants of binding specificity and partner selection that static structures alone cannot capture.
Abstract
Whether binding specificity and partner selection in protein-protein interactions (PPIs) can be reliably inferred from static structures or require more dynamic, pathway-resolved energetic analyses remains an open question. To explore this, we focus on the ornithine decarboxylase (ODC)-antizyme isoform 1 (Az1)-antizyme inhibitor (AzIN) system, a well-characterized competitive PPI network that plays a critical role in regulating polyamine homeostasis. By combining extensive all-atom molecular dynamics simulations with biochemical experiments and the development of a new tool, we uncover key dynamic features of the static and recognition pathway interaction. Based on these, we designed novel antizyme isoforms (NAZs). Our analysis, using residue-resolved energetic landscapes, reveals critical determinants of binding specificity and partner selection that static structures alone cannot capture. These insights guide the engineering of NAZs that either directly engage ODC or modulate Az1 availability. This work provides a new perspective, demonstrating that dynamic energetic landscapes, rather than static structures, are key to understanding and modulating competitive protein recognition. Additionally, our DyResEL tool enables broader, more detailed analyses of energetic contributions, offering a versatile approach for exploring PPIs in various biological contexts.
The experimentally validated PTM-mediated Ligand Activity Change (PLAC) dataset is curate and finds that the interaction-affecting PTMs usually occur spatially closer to ligands than the interaction-neutral ones.
Zi-Hao Wang, Xiao-Wei Xu, Zhe Wang et al.· Journal of Medicinal Chemist...· 0 citations
A framework for accelerating the development of next-generation PPI therapeutics is provided by connecting interface architecture with optimal inhibitor modality and discovery strategy, revealing clear links between interface topology and inhibitor discovery strategies.
Ellie Hyde, A. Beekman· RSC Medicinal Chemistry· 0 citations
Understanding how allosteric modulators influence protein dynamics is essential for guiding drug design. This work analyses a total of 45 μs of classical molecular dynamics simulations for four class A G-protein-coupled receptors (GPCRs), namely the Complement C5a receptor (C5AR1), the Purinergic Receptor P2Y (P2RY1),...
S. Peter, G. Chalhoub, Peter J. McCormick et al.· Journal of Chemical Informat...· 0 citations
A structural database that systematically maps the complete activation trajectories of pharmaceutically relevant targets, encompassing TS, IS, and all connecting conformational ensembles is presented, offering multiple strategic advantages for drug discovery.
A computational, structure-, dynamics-, and energetics-resolved framework for cyclic peptide recognition at the PP2A-B55α regulatory groove is established and testable hypotheses for experimental validation are defined.
Muhammad Waqas, Li Xuan, Haoke Zhang et al.· International Journal of Bio...· 0 citations
Significance Allosteric regulation enables proteins to transmit signals over long distances, but the mechanisms linking local ligand binding to global conformational changes remain difficult to resolve. Here, we combine NMR-based chemical shift covariance analysis with computational contact-response analysis to map the...
Aayushi Singh, Daniel Burns, Sergey L. Sedinkin et al.· Proceedings of the National...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.